Celex Oncology - A new approach to cancer treatment
Channel: Cosmonauts Ltd
Date: 16/01/2023

CELEX Oncology focuses on treating aggressive, invasive and metastatic cancer forms.
Celex is a spin-off from Imperial College, that captures the ground breaking work of Professor Mustafa Djamgoz that has the potential to turn cancer from a life-threatening disease to a chronic illness like high blood pressure.
Professor Djamgoz, pioneered the research that electrical changes in cancer cells turns them from being benign to metastatic cells.
The key breakthrough is that cancer cells develop a unique electrical channel (neonatal voltage-gated sodium channel) that allows sodium ions to continuously flow into the cells. Through a series of events this leads to the cancer cells becoming metastatic and passing into the bloodstream to land on secondary organs.
This is a mechanism of action discovery, and it has the potential to be pan-carcinoma. For all metastatic cancer forms that have been investigated, this has been found to be the case.
Watch the video to learn more about Celex and how to participate in their investment round, supported by Cosmonauts.